Medicare Enrolled

Dr. Todd Kovach, M.D.

Cardiovascular Disease · Clearwater, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
455 PINELLAS ST, Clearwater, FL 33756
7277248611
In practice since 2006 (20 years)
NPI: 1376505362 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kovach from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kovach? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kovach

Dr. Todd Kovach is a cardiovascular disease in Clearwater, FL, with 20 years in practice. Based on federal Medicare data, Dr. Kovach performed 3,246 Medicare services across 2,445 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kovach received a total of $3,751 from 32 pharmaceutical and/or device companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kovach is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 38% volume in FL$ $3,751 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,246
Medicare services
Top 38% in FL for cardiovascular disease
2,445
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~162 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)763$89$311
EKG interpretation and report619$6$20
Hospital follow-up visit, moderate complexity370$62$179
Hospital follow-up visit, high complexity223$93$257
Echocardiogram, transthoracic181$138$470
Initial hospital admission, moderate complexity160$101$433
Electrocardiogram (EKG), 12-lead145$10$35
Regadenoson injection (Lexiscan) for heart stress test117$40$167
Technetium tc-99m tetrofosmin, diagnostic, per study dose112$336$1,056
New patient office visit (45-59 min)90$103$409
Ultrasound of heart with color-depicted blood flow, rate and valve function58$2$8
Nuclear medicine studies of heart muscle at rest and with stress and spect57$329$1,039
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician51$11$35
Ultrasound of both sides of head and neck blood flow43$130$458
Interpretation and report of ultrasound of heart33$69$231
Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days31$18$58
Ultrasound of heart blood flow, valves and chambers30$13$45
Heart rhythm recording continous external ekg over more than 48 hours up to 7 days29$9$28
Ultrasound of heart, follow-up26$19$63
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician25$12$51
Ultrasound of heart blood flow, valves and chambers, follow-up25$6$18
Exercise or drug-induced heart stress test with electrocardiogram (ecg)24$15$85
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional17$20$63
Office visit, established patient (20-29 min)17$65$220
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.1% high complexity
11.6% medium
79.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,751
Total received (2018-2024)
Avg $536/year across 7 years
Top 46% in FL for cardiovascular disease
32
Companies
192
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,628 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$123 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$828
2023
$368
2022
$255
2021
$67
2020
$196
2019
$1,225
2018
$811

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$573
Novartis Pharmaceuticals Corporation
$467
AstraZeneca Pharmaceuticals LP
$345
Amgen Inc.
$328
Medtronic Vascular, Inc.
$254
Boehringer Ingelheim Pharmaceuticals, Inc.
$206
SANOFI-AVENTIS U.S. LLC
$202
PFIZER INC.
$202
Impulse Dynamics (USA) Inc.
$159
Astellas Pharma US Inc
$123
Lexicon Pharmaceuticals, Inc.
$90
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$74
PORTOLA PHARMACEUTICALS, INC.
$63
Alnylam Pharmaceuticals Inc.
$61
Regeneron Healthcare Solutions, Inc.
$59
Actelion Pharmaceuticals US, Inc.
$57
Lundbeck LLC
$55
Amarin Pharma Inc.
$49
CHF Solutions, Inc
$48
SCPHARMACEUTICALS INC.
$45
E.R. Squibb & Sons, L.L.C.
$38
Novo Nordisk Inc
$37
Boston Scientific Corporation
$31
Kestra Medical Technology Services, Inc.
$29
Merck Sharp & Dohme LLC
$25
Allergan Inc.
$25
Kiniksa Pharmaceuticals, Ltd.
$21
Aegerion Pharmaceuticals, Inc.
$21
Gilead Sciences, Inc.
$17
ARALEZ PHARMACEUTICALS US INC.
$17
Abbott Laboratories
$16
Kowa Pharmaceuticals America, Inc.
$15
Top 3 companies account for 36.9% of total payments
Associated products mentioned in payments ›
3F · ANDEXXA · Aquadex · Arcalyst · Assure WCD · BEVYXXA · BRILINTA · BYSTOLIC · CAMZYOS · CARDIOMEMS · CHANTIX · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · FARXIGA · FUROSCIX · Inpefa · JARDIANCE · JUXTAPID · LEQVIO · LEXISCAN · LOKELMA · LifeVest · Livalo · MULTAQ · NORTHERA · ONPATTRO · OPSUMIT · Optimizer · Ozempic · PRADAXA · PRALUENT · Repatha · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · Wegovy · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $116 per 100 Medicare services performed
Looking for a cardiovascular disease in Clearwater?
Compare cardiovascular diseases in the Clearwater area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
202
Per 100K population
21.0
County median income
$70,293
Nearest hospital
MORTON PLANT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kovach is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kovach experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kovach performed 763 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kovach receive payments from pharmaceutical companies?
Yes. Dr. Kovach received a total of $3,751 from 32 companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kovach's costs compare to other cardiovascular diseases in Clearwater?
Dr. Kovach's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kovach) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →